;

3.00 EUR

Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:43:24 PM)
Exchange closed, opens in 15 hours 16 minutes
-1.67 EUR (-1.67%)
-4.53 EUR (-4.53%)
-4.99 EUR (-4.99%)
11.32 EUR (11.32%)
-15.23 EUR (-15.23%)
295.97 EUR (295.97%)
-88.29 EUR (-88.29%)
-93.22 EUR (-93.22%)

About Novacyt SA

Market Capitalization 40.82M

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The company was incorporated in 2006 and is based in Eastleigh, the United Kingdom.

Headquarters (address)

York House

Eastleigh SO53 4DG

United Kingdom

Phone44 2380 748830
Websitehttps://www.novacyt.com
Employees240
SectorHealthcare
IndustryMedical Devices
TickerALNOV
ExchangeEuropean Stock Exchange
CurrencyEUR
52 week range3.00 - 1.59
Market Capitalization40.82M
P/E trailing-1.48
P/E forward2.13
Price/Sale2.20
Price/Book3.00
Beta-1.78
EPS3.00
EPS United Kingdom (ID:3, base:630) 3.00

CleverShares.com|
2024 ©

1.0.9119.29486